Related Experiment Video
Updated: Jul 17, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Supplementation with long-chain polyunsaturated fatty acids to extremely preterm infants associates with development
Hanna Danielsson1,2,3, Theo Portlock1,4, Ann Hellström5
1Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Insights
Arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation impacts the gut microbiome in extremely preterm infants. While this supplementation may influence retinopathy of prematurity (ROP) risk, causality remains undetermined.
Area of Science:
- Neonatal Medicine
- Microbiome Research
- Nutritional Science
Background:
- Supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) is known to reduce severe retinopathy of prematurity (ROP) risk in extremely preterm infants.
- The role of AA:DHA supplementation in the developing gut microbiome and its potential contribution to ROP protection requires further investigation.
- Evaluating additional factors influencing microbiome maturation is crucial for understanding infant gut development.
Purpose of the Study:
- To investigate the impact of AA:DHA supplementation on the gut microbiome composition and function in extremely preterm infants.
- To explore the potential link between AA:DHA supplementation, gut microbiome changes, and the protective effect against severe ROP.
- To identify other covariates that influence the maturation of the infant gut microbiome.
Main Methods:
- Utilized shotgun metagenomics to analyze longitudinal gut microbiome profiles and bacterial gene pathways in 75 extremely preterm infants.
- Integrated serum protein expression data, quantified via proximity extension assays, with microbiome data.
- Conducted a randomized clinical trial to assess the effects of AA:DHA supplementation.
Main Results:
- AA:DHA supplementation was associated with an increased relative abundance of Citrobacter koseri and alterations in protein and metabolic pathways.
- Severe ROP occurrence correlated with microbiome alpha diversity (Shannon, Evenness) and beta diversity (Bray-Curtis).
- Study center and gestational age at birth were identified as significant factors influencing microbiome composition.
Conclusions:
- AA:DHA supplementation demonstrably impacts the gut microbiome in extremely preterm infants.
- The current study could not establish a definitive causal relationship between AA:DHA supplementation, microbiome alterations, and ROP reduction.
- These findings underscore the intricate interaction between nutritional interventions, the gut microbiome, and infant development.
Background:
Supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) to extremely preterm infants reduces the risk of severe retinopathy of prematurity (ROP). The main aim of this study was to explore the involvement of AA:DHA supplementation in the developing gut microbiome, and its possible contribution to the ROP-protective effect. Secondly, additional covariates for microbiome maturation were evaluated.
Methods:
Longitudinal gut microbiome profiles and bacterial gene pathways were characterised using shot-gun metagenomics in 75 extremely preterm infants who participated in a randomized clinical trial on AA:DHA supplementation. Serum protein levels quantified using proximity extension assays were merged with the microbiome data.
Results:
AA:DHA supplementation was linked to an increase in relative abundance of Citrobacter koseri and associated with changes in proteins and metabolic pathways. Occurrence of severe ROP was associated with microbiome alpha diversity (Shannon and Evenness) and beta diversity (Bray-Curtis). Additionally, study centre and gestational age at birth impacted the microbiome composition.
Conclusion:
We conclude that AA:DHA supplementation impacts the microbiome. However, the current study could not determine the causality between the supplementation, microbiome and ROP-decrease. Nonetheless, these findings highlight the complex interplay between external interventions, including nutritional supplements, and the gut microbiome development in extremely preterm infants.
Impact:
Longitudinal gut microbiome profiles, bacterial gene pathways and serum protein expressions were determined using shotgun metagenomics and proximity extension assays in 75 extremely preterm infants included in a multicentre randomized clinical trial investigating enteral fatty acid supplementation. Dynamic shifts in microbiome and pathway composition were seen from birth to 34 weeks gestational age. Arachidonic acid (AA) and docosahexaenoic acid (DHA) supplementation was linked to an increase in relative abundance of Citrobacter koseri and associated with changes in proteins and metabolic pathways. However, the causality between the supplementation, microbiome, and ROP-decrease could not be determined.
Related Concept Videos
Development of Human Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of the Oral Microbiota
Microbiota Modulation by Antibiotics
Introduction to the Human Microbiota
Dysbiosis of the Gut Microbiota
